Natixis Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Sell
20,049
-20,155
-50% -$3.36M ﹤0.01% 1083
2026
Q1
$8.44M Sell
40,204
-19,320
-32% -$4.86M 0.01% 709
2025
Q4
$16.9M Sell
59,524
-7,188
-11% -$2.25M 0.02% 532
2025
Q3
$20.6M Sell
66,712
-952
-1% -$298K 0.03% 475
2025
Q2
$21.3M Buy
67,664
+8,252
+14% +$2.38M 0.03% 449
2025
Q1
$15.6M Buy
59,412
+15,041
+34% +$4.07M 0.03% 517
2024
Q4
$11.6M Buy
44,371
+11,210
+34% +$2.82M 0.02% 610
2024
Q3
$7.72M Buy
33,161
+8,554
+35% +$1.76M 0.02% 720
2024
Q2
$4.97M Buy
24,607
+2,955
+14% +$532K 0.01% 797
2024
Q1
$3.71M Sell
21,652
-8,231
-28% -$1.53M 0.01% 875
2023
Q4
$6.48M Buy
29,883
+19,396
+185% +$3.33M 0.02% 681
2023
Q3
$1.67M Sell
10,487
-11,148
-52% -$2.5M 0.01% 1037
2023
Q2
$6.24M Sell
21,635
-3,452
-14% -$1.05M 0.02% 652
2023
Q1
$8M Buy
25,087
+1,892
+8% +$561K 0.03% 569
2022
Q4
$6.83M Buy
23,195
+1,576
+7% +$435K 0.03% 589
2022
Q3
$4.96M Buy
21,619
+3,835
+22% +$961K 0.02% 637
2022
Q2
$3.88M Sell
17,784
-163
-0.9% -$37.1K 0.02% 725
2022
Q1
$4.78M Buy
+17,947
New +$4.4M 0.02% 697

Other funds holding PODD

Natixis Advisors's PODD Position: Q2 2026 in Review

Natixis Advisors reduced its Insulet (PODD) stake by 50% in Q2 2026, selling an estimated $3.36M and leaving 20,049 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Natixis Advisors first reported a position in PODD in Q1 2022 and has held it in 18 quarters since. The position peaked at $21.3M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Natixis Advisors held 20,049 shares of Insulet worth $3.05M as of Q2 2026.
  • Natixis Advisors sold 20,155 Insulet shares in Q2 2026, an estimated $3.36M.
  • Insulet made up ﹤0.01% of Natixis Advisors's portfolio in Q2 2026, its #1083 holding.
  • Natixis Advisors first reported a position in Insulet in Q1 2022 and has held it in 18 quarters since.
  • Natixis Advisors's Insulet position peaked at $21.3M in Q2 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.